Expression and purification of recombinant immunotoxin - A fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition

Protein Expression and Purification

Volumn 27, Issue 1, 2003, Pages 85-89

  Kim, Se Ho ^a  

^a Green Cross Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; PSEUDOMONAS;

BACTERIAL TOXIN; CARCINOEMBRYONIC ANTIGEN; EXOTOXIN; GUANIDINE; HYBRID PROTEIN; IMMUNOTOXIN; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TOXA PROTEIN, PSEUDOMONAS AERUGINOSA; VIRULENCE FACTOR;

ARTICLE; CHEMISTRY; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; PSEUDOMONAS AERUGINOSA;

ADP RIBOSE TRANSFERASES; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CARCINOEMBRYONIC ANTIGEN; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOTOXINS; GENE EXPRESSION; GUANIDINE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTOXINS; PSEUDOMONAS AERUGINOSA; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS;

EID: 0042785200     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00539-9     Document Type: Article

References (24)

1. S. Benchimol, A. Fuks, S. Jothy, N. Beauchemin, K. Shirota, C.P. Stanners, Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule, Cell (1989) 57:327-334.
2. A.M. Wu, W. Chen, A. Raubitschek, L.E. Williams, M. Neumaier, R. Fischer, S.Z. Hu, T. Odom-Maryon, J.Y. Wong, J.E. Shively, Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers, Immunotechnology 2 (1996) 21-36.
3. P. Maxwell, Carcinoembryonic antigen: cell adhesion molecule and useful diagnostic marker, Br. J. Biomed. Sci. 56 (1999) 209-214.
4. T.A. Waldmann, Monoclonal antibodies in diagnosis and therapy, Science 252 (1991) 1657-1662.
5. K.A. Chester, A. Mayer, J. Bhatia, L. Robson, D.I. Spencer, S.P. Cooke, A.A. Flynn, S.K. Sharma, G. Boxer, R.B. Pedley, R.H. Begent, Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer, Cancer Chemother. Pharmacol. 46 (Suppl.) (2000) S8-S12.
6. M. Juweid, R.M. Sharkey, T.M. Behr, L.C. Swayne, R. Dunn, Z. Ying, J.A. Siegel, H.J. Hansen, D.M. Goldenberg, Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2, Cancer 78 (1996) 157-168.
7. S. Hu, L. Shively, A. Raubitschek, M. Sherman, L.E. Williams, J.Y. Wong, J.E. Shively, A.M. Wu, Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts, Cancer Res. 56 (1996) 3055-3061.
8. A. Mayer, K.A. Chester, A.A. Flynn, R.H. Begent, Taking engineered anti-CEA antibodies to the clinic, J. Immunol. Meth. 231 (1999) 261-273.
9. R.J. Kreitman, Immunotoxins in cancer therapy, Curr. Opin. Immunol. 11 (1999) 570-578.
10. U. Brinkmann, Recombinant immunotoxins: protein engineering for cancer therapy, Mol. Med. Today 2 (1996) 439-446.
11. M. Onda, T. Olafsen, Y. Tsutsumi, O.S. Bruland, I. Pastan, Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated pseudomonas exotoxin A, J. Immunother. 24 (2001) 144-150.
12. C.T. Kuan, Q.C. Wang, I. Pastan, Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner, J. Biol. Chem. 269 (1994) 7610-7616.
13. R. Niv, C.J. Cohen, G. Denkberg, D. Segal, Y. Reiter, Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxins, Curr. Pharm Biotechnol. 2 (2001) 19-46.
14. V.S. Allured, R.J. Collier, S.F. Carroll, D.B. McKay, Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution, Proc. Natl. Acad. Sci. USA 83 (1986) 1320-1324.
15. J. Hwang, D.J. Fitzgerald, S. Adhya, I. Pastan, Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in, E. coli, Cell 48 (1987) 129-136.
16. S.H. Kim, J.H. Chun, S.Y. Park, Characterization of monoclonal antibodies against carcinoembryonic antigen (CEA) and expression in, E. coli, Hybridoma 20 (2001) 265-272.
17. S.H. Kim, D.G. Schindler, A.B. Lindner, D.S. Tawfik, Z. Eshhar, Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies, Mol. Immunol. 34 (1997) 891-906.
18. S.H. Kim, S.H. Song, Y.J. Kim, S.Y. Park, Expression and characterization of a recombinant Fab fragment derived from an anti-human α-fetoprotein (AFP) monoclonal antibody, Mol. Cells 11 (2001) 158-163.
19. J. Buchner, I. Pastan, U. Brinkmann, A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies, Anal. Biochem. 205 (1992) 263-270.
20. M. Onda, S. Nagata, Y. Tsutsumi, J.J. Vincent, Q. Wang, R.J. Kreitman, B. Lee, I. Pastan, Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity, Cancer Res. 61 (2001) 5070-5077.
21. J. Anthony, R. Near, S.L. Wong, E. Iida, E. Ernst, M. Wittekind, E. Haber, S.C. Ng, Production of stable anti-digoxin Fv in Escherichia coli, Mol. Immunol. 29 (1992) 1237-1247.
22. U. Brinkmann, J. Buchner, I. Pastan, Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections, Proc. Natl. Acad. Sci. USA 89 (1992) 3075-3079.
23. B. Matthey, A. Engert, A. Klimka, V. Diehl, S. Barth, A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins, Gene 229 (1999) 145-153.
24. H.D. Ulrich, P.A. Patten, P.L. Yang, F.E. Romesberg, P.G. Schultz, Expression studies of catalytic antibodies, Proc. Natl. Acad. Sci. USA 92 (1995) 11907-11911.